Series A

Arintra Secures $21M Series A to Revolutionize Healthcare Reimbursements

Investorsync desk1 min read

Deal sheet

$21M

Stage
Series A
Announced
13 August 2025

Arintra has raised $21 million in Series A funding led by Peak XV Partners, with participation from Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Spider Capital, TEN13, and other strategic investors.

Founded by Nitesh Shroff and Preeti Bhargava in 2020.

Arintra is building a GenAI-native autonomous medical coding platform for healthcare providers, automating the conversion of clinical documentation into accurate insurance codes while integrating clinical documentation improvement (CDI) and denials prevention within a single platform.

The fresh capital will be used to drive adoption across U.S. health systems and physician groups, accelerate product development, scale the team, and launch a new Bay Area headquarters.

Arintra’s business model helps healthcare providers achieve full, compliant reimbursements while lowering costs, improving claim accuracy, and speeding up cash flow.

Operating as an enterprise SaaS, it integrates with EHR systems like Epic and Athena to function seamlessly within existing workflows.

Source: company announcement. First posted on the Investorsync LinkedIn page.

From InvestorDB

Investors in this round.

Keep reading

The Sync Report

All Rounds